HORUS
@horus-urbanhealth.eu
NCDs, especially diabetes and cardiovascular diseases (CVDs), are the leading causes of morbidity and mortality worldwide. CVDs kill more people globally than any other disease, accounting for 17.9 million deaths per year. Diabetes, on the other hand, accounts for 2 million deaths annually. These diseases have a greater impact on vulnerable populations. This increased prevalence among this population is related to a range of social and environmental factors, lifestyles, and the impact of behavioural determinants. Low-income communities, such as migrants or ethnic minorities, are still undertreated and unprotected by most of the healthcare systems with a lack of quality of care for NCDs and a lack of preventive measures specifically adapted for them. Thus, HORUS aims to tackle NCDs, especially diabetes and CVDs, in urban built environments among vulnerable populations, mainly low-income communities, migrants and ethnic minorities. In particular, it has a twofold objective. (1) First, to analyse and explore in depth the causal links between the characteristics of the urban built environment and the prevalence of NCD risk behaviours in an integrated, comprehensive and multiapproach manner. HORUS will focus on existing urban interventions modifying the physical-social and functional characteristics of the built environment with a significant impact on the prevalence of risk behaviours and, eventually, NCD outcomes. (2) And, secondly, to develop pilot interventions in three European countries –Spain, Croatia and The Netherlands– to promote behaviour change towards healthier lifestyles for empowering vulnerable populations, and to support citizens in making optimal use of the urban environment they live in while reducing NCD risk behaviours, especially those related to diabetes and CVDs.
HORUS's Company Logos
HORUS's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#99C54E
Celery
153, 197, 78
82, 51, 54
22, 0, 60, 23
#CAF880
Mindaro
202, 248, 128
83, 90, 74
19, 0, 48, 3
#666C62
Willow Grove
102, 108, 98
96, 5, 40
6, 0, 9, 58
About HORUS
Bax & Company is a prominent European innovation consultancy that assists corporate leaders, entrepreneurs, and policymakers in developing and managing cutting-edge science and technology initiatives with significant societal, environmental, and economic impacts. They work towards creating, executing, and overseeing projects that drive positive change through innovation. Partnering with institutions like Erasmus MC, Sveuciliste u Rijeci, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, and more, Bax & Company leverages expertise to address health-related social challenges.
They provide services like consulting, strategic guidance, and coordination for securing European funding for impactful projects. With a focus on innovation, research, development, and societal improvement, Bax & Company plays a crucial role in shaping a better future through their collaborative efforts with various organizations and institutions
